Design Therapeutics, Inc. (DSGN) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: DSGN) | Delayed: 10.63 +0.29 (2.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.34 | 52 Week High | $ | |||
| Open | $10.29 | 52 Week Low | $ | |||
| Day High | $10.80 | P/E | N/A | |||
| Day Low | $10.13 | EPS | $ | |||
| Volume | 388,875 | |||||
